These final results, together with a past report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 guidance the strategy of targeting ACKR3 as a unique solution to modulate the opioid technique, which could open up new therapeutic avenues for opioid-linked Problems. Once in a while https://annieh110dui0.newsbloger.com/profile